Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease

Lancet

Volumn 347, Issue 8999, 1996, Pages 436-440

  Barberà, Joan A ^a   Roger, Núria ^a   Roca, Josep ^a   Rovira, Irene ^a   Higenbottam, Timothy W ^b   Rodriguez Roisin, Robert ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; OXYGEN;

ADULT; ARTERIAL OXYGEN TENSION; ARTERY DILATATION; ARTICLE; BLOOD GAS ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG GAS EXCHANGE; LUNG HEMODYNAMICS; MALE; PRIORITY JOURNAL; RESPIRATORY DISTRESS;

EID: 0030040551     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90011-2     Document Type: Article

References (24)

1. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991; 338: 1173-74.
2. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83: 2038-47.
3. Rossaint R, Falke KJ, López F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328: 399-405.
4. Mira JP, Monchi M, Brunet F, Fierobe L, Dhainaut JF, Dinh-Xuan AT. Lack of efficacy of inhaled nitric oxide in ARDS. Intensive Care Med 1994; 20: 532.
5. Ricou B, Suter PM. Variable effects of nitric oxide (NO) in ARDS patients. Am Rev Respir Dis 1993; 147: A350 (abstr).
6. Adnot S, Kouyoumdjian C, Defouilloy C, et al. Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am Rev Respir Dis 1993; 148: 310-16.
7. A/Q̇ inequalities in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 149: 1482-87.
8. Mélot C, Hallemans R, Naeije R, Mois P, Lejeune P. Deleterious effect of nifedipine on pulmonary gas exchange in chronic obstructive pulmonary disease. Am Rev Respir Dis 1984; 130: 612-16.
9. Agustí AGN, Barberà JA, Roca J, Wagner PD, Guitart R, Rodriguez-Roisin R. Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease. Chest 1990; 97: 268-75.
10. Weitzenblum E, Kessler R, Oswald M, Fraisse Ph. Medical treatment of pulmonary hypertension in chronic lung disease. Eur Respir J 1994; 7: 148-52.
11. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-44.
12. Roca J, Wagner PD. Contribution of multiple inert gas elimination technique to pulmonary medicine 1: principles and information content of the multiple inert gas elimination technique. Thorax 1994; 49: 815-24.
13. Wagner PD, Hedenstierna G, Bylin G. Ventilation-perfusion inequality in chronic asthma. Am Rev Respir Dis 1987; 136: 605-12.
14. Gale GE, Torre-Bueno JR, Moon RE, Saltzman HA, Wagner PD. Ventilation-perfusion inequality in normal humans during exercise at sea level and simulated altitude. J Appl Physiol 1985; 58: 978-88.
15. Wagner PD, Dantzker DR, Dueck R, Clausen JL, West JB. Ventilation-perfusion inequality in chronic obstructive pulmonary disease. J Clin Invest 1977; 59: 203-16.
16. Barberà JA, Ramírez J, Roca J, Wagner PD, Sánchez-Lloret J, Rodriguez-Roisin R. Lung structure and gas exchange in mild chronic obstructive pulmonary disease. Am Rev Respir Dis 1990; 141: 895-901.
17. 2 breathing. J Appl Physiol 1975; 38: 886-95.
18. Barberà JA, Riverola A, Roca J, et al. Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 149: 423-29.
19. Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM. Inhaled nitric oxide selectively reverses human hypoxic vasoconstriction without causing systemic vasodilation. Anesthesiology 1993; 78: 427-35.
20. Pison U, López FA, Heidelmeyer CF, Rossaint R, Falke KJ. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange. J Appl Physiol 1993; 74: 1287-92.
21. Reyes A, Roca J, Rodriguez-Roisin R, Torres A, Ussetti P, Wagner PD. Effect of almitrine on ventilation-perfusion distribution in adult respiratory distress syndrome. Am Rev Respir Dis 1988; 137: 1062-67.
22. Walmrath D, Schenider T, Pilch J, Schermuly R, Grimminger F, Seeger W. Effects of aerosolized prostacyclin in severe pneumonia: impact of fibrosis. Am J Respir Crit Care Med 1995; 151: 724-30.
23. Gerlach H, Rossaint R, Pappert D, Falke KJ. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993; 23: 445-47.
24. Sprague RS, Thiemermann C, Vane JR. Endogenous endothelium-derived relaxing factor opposes hypoxic pulmonary vasoconstriction and supports blood flow to hypoxic alveoli in anesthetized rabbits. Proc Natl Acad Sci USA 1992; 89: 8711-15.